Sotera Health Company (NASDAQ:SHC) Given Average Recommendation of "Moderate Buy" by Brokerages

Sotera Health Company (NASDAQ:SHC - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $17.20.

A number of brokerages recently commented on SHC. Barclays raised their price objective on shares of Sotera Health from $17.00 to $19.00 and gave the stock an "overweight" rating in a report on Thursday, October 2nd. Wall Street Zen upgraded shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of Sotera Health in a research note on Wednesday.

Sotera Health Trading Down 1.4%

Shares of NASDAQ:SHC opened at $15.78 on Friday. Sotera Health has a 12 month low of $9.53 and a 12 month high of $16.64. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. The company's fifty day simple moving average is $15.42 and its 200 day simple moving average is $12.95. The firm has a market cap of $4.48 billion, a price-to-earnings ratio of 197.27 and a beta of 1.82.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Friday, August 8th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The business had revenue of $294.34 million for the quarter, compared to analyst estimates of $275.81 million. During the same period last year, the business posted $0.19 earnings per share. The firm's quarterly revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, research analysts forecast that Sotera Health will post 0.61 EPS for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 8,000,000 shares of Sotera Health stock in a transaction on Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $120,880,000.00. Following the sale, the director directly owned 41,215,301 shares in the company, valued at approximately $622,763,198.11. The trade was a 16.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Pincus & Co. Warburg sold 12,000,000 shares of Sotera Health stock in a transaction on Friday, September 5th. The shares were sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the completion of the sale, the director owned 61,822,952 shares in the company, valued at $934,144,804.72. The trade was a 16.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 20,126,611 shares of company stock worth $304,273,888. Insiders own 47.55% of the company's stock.

Institutional Investors Weigh In On Sotera Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC increased its stake in shares of Sotera Health by 55.9% during the 2nd quarter. Farther Finance Advisors LLC now owns 9,861 shares of the company's stock worth $110,000 after purchasing an additional 3,534 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Sotera Health during the 1st quarter worth about $266,000. Strs Ohio acquired a new position in shares of Sotera Health during the 1st quarter worth about $1,003,000. Principal Financial Group Inc. increased its stake in shares of Sotera Health by 0.3% during the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock worth $4,109,000 after purchasing an additional 1,037 shares during the last quarter. Finally, Public Employees Retirement System of Ohio increased its stake in shares of Sotera Health by 4.0% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 48,635 shares of the company's stock worth $541,000 after purchasing an additional 1,891 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.